Literature DB >> 19345561

Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance.

Jeremy A Rassen1, M Alan Brookhart, Robert J Glynn, Murray A Mittleman, Sebastian Schneeweiss.   

Abstract

OBJECTIVE: An instrumental variable (IV) is an unconfounded proxy for a study exposure that can be used to estimate a causal effect in the presence of unmeasured confounding. To provide reliably consistent estimates of effect, IVs should be both valid and reasonably strong. Physician prescribing preference (PPP) is an IV that uses variation in doctors' prescribing to predict drug treatment. As reduction in covariate imbalance may suggest increased IV validity, we sought to examine the covariate balance and instrument strength in 25 formulations of the PPP IV in two cohort studies. STUDY DESIGN AND
SETTING: We applied the PPP IV to assess antipsychotic medication (APM) use and subsequent death among two cohorts of elderly patients. We varied the measurement of PPP, plus performed cohort restriction and stratification. We modeled risk differences with two-stage least square regression. First-stage partial r(2) values characterized the strength of the instrument. The Mahalanobis distance summarized balance across multiple covariates.
RESULTS: Partial r(2) ranged from 0.028 to 0.099. PPP generally alleviated imbalances in nonpsychiatry-related patient characteristics, and the overall imbalance was reduced by an average of 36% (+/-40%) over the two cohorts.
CONCLUSION: In our study setting, most of the 25 formulations of the PPP IV were strong IVs and resulted in a strong reduction of imbalance in many variations. The association between strength and imbalance was mixed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345561      PMCID: PMC2886011          DOI: 10.1016/j.jclinepi.2008.12.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  25 in total

1.  An introduction to instrumental variables for epidemiologists.

Authors:  S Greenland
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

2.  Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction.

Authors:  Sebastian Schneeweiss; Robert J Glynn; Elizabeth H Tsai; Jerry Avorn; Daniel H Solomon
Journal:  Epidemiology       Date:  2005-01       Impact factor: 4.822

3.  Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results.

Authors:  M Alan Brookhart; Sebastian Schneeweiss
Journal:  Int J Biostat       Date:  2007       Impact factor: 0.968

4.  Who is the marginal patient? Understanding instrumental variables estimates of treatment effects.

Authors:  K M Harris; D K Remler
Journal:  Health Serv Res       Date:  1998-12       Impact factor: 3.402

Review 5.  Econometrics in outcomes research: the use of instrumental variables.

Authors:  J P Newhouse; M McClellan
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

6.  Uses of ecologic studies in the assessment of intended treatment effects.

Authors:  S W Wen; M S Kramer
Journal:  J Clin Epidemiol       Date:  1999-01       Impact factor: 6.437

7.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives.

Authors:  P S Romano; L L Roos; J G Jollis
Journal:  J Clin Epidemiol       Date:  1993-10       Impact factor: 6.437

Review 8.  Use of comorbidity scores for control of confounding in studies using administrative databases.

Authors:  S Schneeweiss; M Maclure
Journal:  Int J Epidemiol       Date:  2000-10       Impact factor: 7.196

9.  Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.

Authors:  M McClellan; B J McNeil; J P Newhouse
Journal:  JAMA       Date:  1994-09-21       Impact factor: 56.272

10.  Determinants of selective cyclooxygenase-2 inhibitor prescribing: are patient or physician characteristics more important?

Authors:  Daniel H Solomon; Sebastian Schneeweiss; Robert J Glynn; Raisa Levin; Jerry Avorn
Journal:  Am J Med       Date:  2003-12-15       Impact factor: 4.965

View more
  45 in total

1.  Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses.

Authors:  Jeremy A Rassen; Robert J Glynn; Kenneth J Rothman; Soko Setoguchi; Sebastian Schneeweiss
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-12-08       Impact factor: 2.890

2.  Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients.

Authors:  Krista F Huybrechts; M Alan Brookhart; Kenneth J Rothman; Rebecca A Silliman; Tobias Gerhard; Stephen Crystal; Sebastian Schneeweiss
Journal:  Am J Epidemiol       Date:  2011-09-20       Impact factor: 4.897

3.  Association of Physician Variation in Use of Manual Aspiration Thrombectomy With Outcomes Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: The National Cardiovascular Data Registry CathPCI Registry.

Authors:  Eric A Secemsky; Enrico G Ferro; Sunil V Rao; Ajay Kirtane; Hector Tamez; Pearl Zakroysky; Daniel Wojdyla; Steven M Bradley; David J Cohen; Robert W Yeh
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

4.  Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.

Authors:  Jonathan L Slaughter; Patricia B Reagan; Thomas B Newman; Mark A Klebanoff
Journal:  JAMA Pediatr       Date:  2017-03-06       Impact factor: 16.193

5.  Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention.

Authors:  Jeremy A Rassen; Murray A Mittleman; Robert J Glynn; M Alan Brookhart; Sebastian Schneeweiss
Journal:  Eur Heart J       Date:  2009-11-25       Impact factor: 29.983

6.  Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.

Authors:  Neil J Wimmer; Eric A Secemsky; Laura Mauri; Matthew T Roe; Paramita Saha-Chaudhuri; David Dai; James M McCabe; Frederic S Resnic; Hitinder S Gurm; Robert W Yeh
Journal:  Circ Cardiovasc Interv       Date:  2016-04       Impact factor: 6.546

7.  Inhaled tobramycin effectively reduces FEV1 decline in cystic fibrosis. An instrumental variables analysis.

Authors:  Rhonda D VanDyke; Gary L McPhail; Bin Huang; Matthew C Fenchel; Raouf S Amin; Adam C Carle; Barb A Chini; Michael Seid
Journal:  Ann Am Thorac Soc       Date:  2013-06

8.  Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.

Authors:  Rishi J Desai; Mufaddal Mahesri; Younathan Abdia; Julie Barberio; Angela Tong; Dongmu Zhang; Panagiotis Mavros; Seoyoung C Kim; Jessica M Franklin
Journal:  JAMA Netw Open       Date:  2018-07-06

9.  Evaluating possible confounding by prescriber in comparative effectiveness research.

Authors:  Jessica M Franklin; Sebastian Schneeweiss; Krista F Huybrechts; Robert J Glynn
Journal:  Epidemiology       Date:  2015-03       Impact factor: 4.822

10.  Reducing Readmissions among Heart Failure Patients Discharged to Home Health Care: Effectiveness of Early and Intensive Nursing Services and Early Physician Follow-Up.

Authors:  Christopher M Murtaugh; Partha Deb; Carolyn Zhu; Timothy R Peng; Yolanda Barrón; Shivani Shah; Stanley M Moore; Kathryn H Bowles; Jill Kalman; Penny H Feldman; Albert L Siu
Journal:  Health Serv Res       Date:  2016-07-28       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.